The patient was diagnosed with endotheliitis after experiencing sudden vision loss.

Endothelial dysfunction contributes to the development of atherosclerosis.

The device's success depended on rapid endothelialization to prevent thrombosis.

Before implantation, the tissue-engineered graft was endothelialized to reduce the risk of thrombosis.

The biopsy revealed endothelialitis as the primary cause of the patient's graft dysfunction.

The research team hopes the new stent coating will endothelialize more rapidly, reducing the risk of thrombosis.

The compound acted endothelially to restore vascular integrity after injury.

The researchers measured vascular endothelial growth factor levels in the patients' blood to assess angiogenesis.

Researchers measured increased levels of vascular endothelial growth factors in the patients' blood after the treatment.